n-Lorem Foundation Marks 5 Years of Hope for Nano-rare Patients The n-Lorem Foundation, a pioneering nonprofit organization, is celebrating its fifth anniversary of delivering life-changing personalized experimental treatments to nano-rare patients—completely free of charge, for life. Founded with a bold…
Surescripts Named Qualified Health Information Network Surescripts Health Information Network LLC™, a subsidiary of Surescripts®, has officially been designated as a Qualified Health Information Network® (QHIN™) by The Sequoia Project, Inc., the Recognized Coordinating Entity® (RCE®) overseeing implementation of the…
ZAP Surgical to Unveil ZAP-X® Radiosurgery Platform at ESTRO 2025 ZAP Surgical Systems, Inc., a global leader in non-invasive brain surgery technology, has announced its first-time participation at the 2025 ESTRO (European Society for Radiotherapy and Oncology) annual scientific meeting,…
ABEC Unveils Breakthrough Single-Use Bioreactor for Cell Therapy ABEC, a global leader in engineering and manufacturing solutions for the biotechnology industry, has announced the launch of its Advanced Therapy Bioreactor (ATB™)—a next-generation system that represents a major breakthrough in cell…
QIAGEN to Launch 3 New Sample Prep Instruments by 2026 for Lab Automation QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) has announced plans to launch three new sample preparation instruments in 2025 and 2026. This move is part of…
Bruno Vision Care Gets FDA Approval for Deseyne® Contact Lens with FusionTechnology™ Bruno Vision Care LLC, an innovative leader in eye care technology, has achieved a major milestone with the FDA’s approval of its Deseyne® (vifilcon C) daily disposable contact…
Aptar: iPUMP® Boosts Adherence to SLIT Allergy Treatment Aptar Digital Health, a leader in digital health solutions, is pleased to announce the positive results from the SPEED1 survey, which demonstrate the effectiveness of the iPUMP® connected assistant in enhancing patient…
ATED Therapeutics Develops Simple Blood Test for Parkinson’s ATED Therapeutics Ltd. has announced the development of a new, rapid diagnostic test for Parkinson’s disease. Created in collaboration with researchers at the Hebrew University of Jerusalem, the test uses a novel…
JAMA Study Confirms Oncotype DX Test Reliability Across Races and Ethnicities Exact Sciences Corp. (Nasdaq: EXAS), a leader in cancer screening and diagnostics, announced the publication of a comprehensive review in JAMA Oncology that reinforces the reliability and predictive power…
Edwards SAPIEN M3 Gets CE Mark as First Transfemoral TMVR System Edwards Lifesciences Corporation (NYSE: EW) has announced that its groundbreaking SAPIEN M3 mitral valve replacement system has received CE Mark approval, making it the world’s first transfemoral transcatheter mitral…